These results suggested that ME might alleviate obesity-induced inflammation and mitochondrial dysfunction by regulating miR-21, miR-132, and miR-43 expression in WAT, and by activating the PGC-1α/SIRT1 pathway in muscle. The gene discussed is PPARGC1A; the disease is obesity due to melanocortin 4 receptor deficiency.